Parallax Volatility Advisers
WVE icon

Parallax Volatility Advisers’s Wave Life Sciences WVE Stock Holding History

Parallax Volatility Advisers’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,806
Closed -$63K – 4429
2017
Q4 		$63K Buy
+1,806
New +$52.7K ﹤0.01% 3090

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Parallax Volatility Advisers's WVE Position: Q1 2018 in Review

Parallax Volatility Advisers sold out of Wave Life Sciences (WVE) in Q1 2018, closing a stake of 1,806 shares — an estimated $63K sold.

Parallax Volatility Advisers first reported a position in WVE in Q4 2017 and held it in 1 quarter. The position peaked at $63K in Q4 2017. 79 funds tracked by Wall St. Rank hold WVE as of Q1 2018.

  • Parallax Volatility Advisers reported no remaining Wave Life Sciences position as of Q1 2018 after selling out during the quarter.
  • Parallax Volatility Advisers sold 1,806 Wave Life Sciences shares in Q1 2018, an estimated $63K.
  • Parallax Volatility Advisers first reported a position in Wave Life Sciences in Q4 2017 and held it in 1 quarter.
  • Parallax Volatility Advisers's Wave Life Sciences position peaked at $63K in Q4 2017.
  • 79 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2018.

Based on Parallax Volatility Advisers's 13F filing for Q1 2018, filed 15 May 2018.